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Abstract Guanine nucleotides (GNs), including GMP, displace 
[3H]kainic acid binding to chick cerebellar lysed and vesiculated 
membranes. Saturation studies of [3H]GppNHp binding, under 
conditions that prevent the occupation of the nucleotide binding 
sites in G-proteins, demonstrate the existence of extracellular 
membrane receptors specific for guanine nucleotides. Affinity-
labeling of a vesicle preparation with [a-3 2P]GTP gives one 
single labeled band, upon electrophoresis, with an apparent 
molecular mass of 50 kDa. Additional experiments with partially 
purified kainate receptors suggest that the GN extracellular sites 
may overlap, at least partially, the kainic acid binding sites, 
being then responsible for the displacement of |3H]kainic acid by 
GNs. The physiological significance of these findings remains 
unclear. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The role of the guanine nucleotides (GNs) G T P and G D P 
in the activation/inactivation cycle of G-proteins and other 
intracellular GTPases involved in cell-signalling-related proc-
esses is well understood [1^1]. One of the constant features of 
G-protein-coupled receptors is the displacement of agonists 
(but not of antagonists) by either G T P or G D P , and their 
analogs. In the case of ionotropic glutamate receptors, how-
ever, the displacement of different agonists by GNs , under 
conditions that presumably exclude the hypothetical coupling 
of these receptors to G-proteins, has been reported ([5-11] but 
see also [12]). We have furthermore demonstrated that 
[3H]kainic acid (KA) is displaced not only by G T P and 
G D P , but also by G M P (which is never active on G-pro-
tein-coupled receptors) in chick tectal and cerebellar mem-
branes [8]. The displacement of specific [3H]KA binding by 
G N s is not modified by pre-saturation of the nucleotide sites 
of G-proteins with G p p N H p , and we have recently concluded 
that G N s displace K A acting extracellularly at, or close to, 
the K A receptor itself [11]. This furthermore agrees with our 
own results using closed membrane vesicles, where G-proteins 
are not accessible to the G N s [8]. In the present paper we 
describe the characterization of these extracellular G N bind-
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ing sites by means of [ 3 H]GppNHp, a non-hydrolyzable G T P 
analog, and explore the relationship between the new G N sites 
and the K A receptor sites. 
2. Materials and methods 
2.1. Animals 
Young white Leghorn chicks (10+1 days old) were raised in our 
facilities. They were kept at 37°C, on a 12-h light/12-h darkness cycle. 
2.2. Materials 
p\y-Imido[8-3H]guanosine 5'-triphosphate (GppNHp: 19.8 Ci/ 
mmol) and [a-32P]GTP ( > 400 Ci/mmol) were obtained from Amer-
sham International, UK; [3H]kainic acid (58 Ci/mmol) was from New 
England Nuclear, Germany; protein kinase, for cAMP determina-
tions, guanine nucleotides and ATP were from Sigma or Boehringer 
Mannheim. All other chemicals were obtained from standard com-
mercial suppliers. 
2.3. Membrane preparations 
Lysed and vesiculated membrane preparations were carried out at 
4°C as described previously [8,11], with some modifications to im-
prove yield and reproducibility. 
In the case of lysed membranes, 10-day chick cerebella were homo-
genized (Dounce glass/glass homogenizer, A+B pestles) in 20 volumes 
of 0.32 M sucrose prepared in 10 mM Tris-HCl buffer, pH 7.4, con-
taining 1 mM MgCl2. The homogenate was centrifuged at lOOOXg for 
15 min, and the pellet resuspended and centrifuged again. The second 
pellet was discarded and the supernatants pooled and centrifuged at 
lOOOOOXg for 30 min. The resulting pellet was lysed in 20 volumes 
(relative to initial weight) of 1 mM Tris-HCl buffer, pH 7.4, for 30 
min, and centrifuged at lOOOOOXg as above. This pellet was washed 
twice more in lysis buffer, under the same conditions, and resuspended 
finally in 10 mM Tris-HCl buffer, pH 7.4, at an adequate protein 
concentration, for use in binding (and other) experiments. 
When preparing closed membrane vesicles, the cerebella were first 
carefully minced and then homogenized (Dounce homogenizer, A 
pestle only) in a Krebs-Ringer solution comprising 122 mM NaCl, 
3 mM KC1, 1.2 mM MgS04 , 1.3 mM CaCl2, 0.4 mM KH 2P0 4 and 10 
mM glucose, adjusting the pH to 7.4 with 100 mM Na 2HP0 4 (KRG). 
Differential centrifugation steps and washings were carried out as with 
lysed membranes, but using only the A pestle for a more gentle re-
suspension of vesicles. The integrity and sidedness (inside-in) of the 
vesicle preparation was checked before binding experiments by meas-
uring the ability of GppNHp to stimulate adenylate cyclase (methods 
as in [11]), so to confirm the non-accessibility of G-proteins. Vesicle 
preparations with higher than 5% sensitivity to GppNHp stimulation 
were discarded. 
2.4. Binding assays 
Binding assays of [3H]GppNHp or [3H]KA were performed at 30°C 
in small polycarbonate tubes (total volume 1 ml), containing 10 mM 
Tris-HCl, pH 7.4 (or KRG in the case of vesicles), 0.3 mg membrane 
protein, and the radioactive ligand, with or without the displacer 
(non-radioactive ligand). Incubation was started by addition of mem-
branes and terminated after 30 min by centrifugation at 12000Xg for 
30 min (as efficient as 30 min at 100000Xg before incubation). The 
supernatant was discarded and the walls of the tubes and the surface 
of the pellets were quickly and carefully rinsed with cold distilled 
water. The pellets were then processed for radioactivity and protein 
determinations. Specific binding was defined as that part of total bind-
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ing displaced by a concentration of non-labeled ligand 104 times the 
radioligand concentration. 
2.5. Discrimination of intracellular (G-protein and related sites) and 
extracellular GN binding sites 
Whereas in the case of membrane vesicles only extracellular binding 
was expected, lysed membranes should contain typical GTP-binding 
sites belonging to G-proteins and related GTPases plus the hypothet-
ical extracellular sites that would explain the interaction between GNs 
and the KA receptor. To give an independent estimate of both types 
of receptors we took advantage of the ability of some non-hydrolyz-
able GTP analogs, such as GppNHp, to bind in a quasi-irreversible 
manner to the nucleotide site of G-proteins [11,13]. Two identical sets 
of samples were assayed in each experiment: in the first set, the part 
of [3H]GppNHp binding resistant to three washes in the absence of 
ligand was considered to represent the G-protein (and related) binding 
sites. To measure the extracellular sites the second set of samples was 
preincubated with an excess (10 uM) of cold GppNHp, so to saturate 
G-protein sites [11]. After three washes as above the preparation was 
again incubated with [3H]GppNHp, as in the general method, to label 
any additional GN binding sites. 
2.6. Affinity labeling of the extracellular GN binding sites 
Freshly prepared membrane vesicle samples were incubated, in a 
multiwell plate, as described in Section 2.4, in the presence of 250 nM 
[cc-32P]GTP. Some wells contained also GppNHp or KA at a 103 X 
concentration. After 15 min, the plate was put over ice and irradiated 
under a GTE Sylvania 15 W UV germicidal (254 nm) lamp (15 min/5 
cm). The samples were transferred to plastic tubes and washed by 
centrifugation. The pellets were finally subjected to SDS-PAGE, 
stained and exposed for autoradiography. 
2.7. Purification of the KA receptor protein 
The KA receptors were partially purified, from our lysed membrane 
preparation, as described in [14]. Triton X-100 was used at 0.5% (v/v), 
this being the concentration that solubilizes a maximum of [3H]KA 
binding sites and a minimum of [3H]GppNHp binding sites (results 
not shown). Only the DEAE-cellulose and the concanavalin A-agar-
ose steps were carried out. Aliquots of the solubilized receptor prep-
aration were assayed for [3H]KA and [3H]GppNHp binding sites at 
different times during the purification. Incubations were for 1 h at 
4°C, and were terminated by precipitation with polyethylene glycol 
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Fig. 1. Competitive displacement of [3H]KA by GppNHp in 10-day 
chick cerebellar membranes. Saturation studies were carried out us-
ing the vesiculated membrane preparation (Section 2.3), varying the 
ligand concentration between 1 and 1000 nM. The graph shows the 
result of a typical experiment which was replicated three times. Con-
trol (O): Kd, 256 nM; Bmax, 403 pmol/mg. GppNHp (•): Aj, 431 
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Fig. 2. Displacement of 40 nM [3H]GppNHp from chick cerebellar 
receptor sites by different GNs and glutamate agonists. The experi-
ments were carried out in a 10-day chick cerebellum lysed mem-
brane preparation. Neither KA nor GLU had any effect at the con-
centrations shown. The figure shows a typical experiment which was 
replicated three times. IC50s: GppNHp, 7X10"
8 M; GTP, 2X10"6 
M; GDP, 5X10"6 M; GMP, 1.5 X 10"4 M. 
carefully washed with 8% polyethylene glycol and incubated overnight 
in 0.1% SDS prior to scintillation counting. Protein values used in 
calculations were input values corrected for carrier protein recovery. 
2.8. Protein measurement 
Protein was measured according to the method of Lowry [15]. 
3. Results 
3.1. Competitive displacement of f3HJKA by GppNHp in 
membrane vesicles 
We have previously characterized KA binding sites in chick 
tectal and cerebellar membranes from pharmacological and 
developmental standpoints [16,17]. We have also shown that 
GNs, including GMP, are efficient displacers of [3H]KA 
[8,11]. In the present paper we just give some additional 
data on the [3H]KA binding to the closed vesicle preparation 
that has proved especially useful to distinguish between intra-
and extracellular GN binding sites. 
Fig. 1 shows again that the non-hydrolyzable GTP analog 
GppNHp, used in this work, is an efficient displacer of 
[3H]KA in chick vesiculated cerebellar membranes. The ki-
netic parameters measured in the presence of the nucleotide 
suggest that the displacement is purely competitive, a result 
compatible with the notion of a direct interference of the GNs 
at the KA receptor site. 
3.2. Characterization of [3HJGppNHp binding sites in chick 
cerebellar membranes 
[3H]GppNHp binds to specific, saturable sites in chick cer-
ebellar membranes. This binding is displaced by all three na-
tive GNs but, surprisingly, is not affected by either KA or 
glutamate (GLU) (Fig. 2). 
The saturation profile of [3H]GppNHp binding sites in 
chick lysed membranes is illustrated in Fig. 3. The curved 
shape of the overall Eadie-Scatchard plot bears out the ex-
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Fig. 3. Saturation analysis of [3H]GppNHp binding sites in 10-day 
chick cerebellar lysed and vesiculated membranes, (o) Eadie-Scatch-
ard plot of binding sites in lysed membranes. (□) G-protein and 
(v) non-G-protein binding sites calculated as described in Section 
2.5. ( T ) Eadie-Scatchard plot of binding sites measured directly on 
vesiculated membranes (extracellular GN sites). The figure shows a 
typical experiment which was replicated three times. The kinetic pa-
rameters are given in Table 1. 
pected complexity of the total population of GN binding sites 
(comprising intra- and extracellular, G-protein- and non-G-
protein-related sites). Trying to characterize the independent 
populations of binding sites that make up the curved plot in 
Fig. 3, we have put aside the usual regression algorithms and 
we have actually tried to ascertain the contributions of the G-
protein-related and non-related sites, as explained in Section 
2.5. In this way, we have been able to distinguish one type of 
binding sites of somewhat higher affinity, which can be quasi-
irreversibly blocked by cold GppNHp, and another lower af-
finity site, which cannot and is therefore a potential candidate 
for the extracellular site. The probable identity of this compo-
nent of the overall binding with the extracellular site (which 
we are looking for) is supported by its near coincidence with 
the independently calculated Eadie-Scatchard plot of the 
[3H]GppNHp binding sites in our closed vesicle preparation, 
as seen in Fig. 3. For comparative purposes, the kinetic con-
stants for the different plots in the figure are summarized in 
Table 1. 
On the other hand, the accessibility to GTP of the GN 
binding sites in the vesicle preparation is confirmed by the 
electrophoretic profiles in Fig. 4. The molecular weight of 
the only labeled band has been calculated as 50 (±1) kDa, 
very close to the published value for the chick cerebellum KA 
receptor [14]. Whereas the presence of an excess of GppNHp 
totally blocks the labeling of the 50 kDa band, KA is unable 
to displace the radioactive GTP, in agreement with the curves 
in Fig. 2. 
3.3. Partial purification of [3H]KA binding sites 
Table 2 summarizes the yield and properties of the solubi-
lized chick cerebellar KA receptors along the different steps of 
the purification process. As seen in Table 2, we have achieved 
a nine-fold purification of the KA binding sites with a simul-
taneous four-fold increase in [3H]GppNHp binding sites, with 
KA binding still more than 80% displaceable by the guanine 
nucleotide, suggesting that the purified KA receptor still re-
tains a GN binding site the occupation of which blocks the 
access of KA to its own membrane receptor [8]. 
Additional experiments (results not shown) were conducted 
with this partially purified receptor. For instance, we still 
could not displace the [3H]GppNHp with 104 times KA (still 
higher concentrations of KA gave erratic results). Finally, to 
better compare the actual number of binding sites for GN and 
KA in the purified receptor preparation we also performed 
binding experiments at high concentrations of tritiated ligand 
(1000 nM, instead of the 40 nM ligand concentration in Table 
2). In four such experiments we measured 1853 ± 167 pmol/mg 
(mean ± S.D.) of KA bound vs. 1594 ± 98 for GppNHp. Tak-
ing into account the 40 nM binding values, and assuming a 
linear Scatchard plot, this would allow a rough estimate of 
KdIBmax values of 420 nM/2640 pmol/mg and 600 nM/2560 
pmol/mg, for KA and GppNHp, respectively. This is a much 
closer match than the 4 to 1 ratio of the respective Bmax values 
obtained in the membrane preparations (Fig. 1 and Table 1). 
4. Discussion 
Ionotropic glutamate receptor agonists, including KA, have 
been shown to be displaced by guanine nucleotides in different 
species and membrane preparations [5-11]. Results with chick 
KA receptors are specially illustrative in this respect [8,10,11]. 
Chick tectal or cerebellar membranes contain abundant me-
dium/low affinity binding sites (Kd in the range of 100-300 
nM) that have been analyzed in different laboratories 
[14,16,17] and, in more recent years, purified and cloned 
[14,18]. 
Our previous studies on the displacement of [3H]KA in 
chick optic tectum and cerebellum by guanine nucleotides, 
including GMP [8,11], have led us to suggest the existence 
of extracellular GN receptors overlapping the KA receptors 
in a way to block the free access of the latter agonist. To 
characterize these hypothetical receptors we analyzed the 
binding of [3H]GppNHp to preparations of lysed or vesicu-
lated chick cerebellar membranes, using specially devised pro-
cedures to discriminate G-protein- and internal GTPase-re-
lated binding sites from the alleged extracellular sites. 
Although more relevant than purely mathematical methods, 
these procedures may possibly overestimate the number of G-
protein sites (due to incomplete washing) so that the graphical 
Table 1 
Kinetic parameters of binding modes in Fig. 3 
Lysed membranes 
G-protein sites (□) (estimated) Non-G-protein sites ( v ) (estimated) 
Vesiculated membranes 
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Fig. 4. Photoaffinity labeling of chick cerebellar proteins that bind 
[o>32P]GTP in a vesiculated membrane preparation. Lane 1: Mem-
brane preparation incubated with 250 nM [a-32P]GTP. Lanes 2 and 
3: Preincubation with 250 u,M GppNHp and 250 uM KA, respec-
tively, prior to exposure to [a-32P]GTP. The molecular weight of 
the labeled band is 50 ± 1 kDa (3 runs). Molecular weight markers 
are, from top to bottom, reduced a2-macroglobulin, phosphorylase 
b, bovine serum albumin and ovalbumin. 
addition of the two discontinuous lines in Fig. 3 would result 
in an composite curve shifted to the right. However, it is 
reassuring to note the excellent agreement between the non-
G-protein component of the overall binding and the inde-
pendent plot of the vesicle preparation, where only the extra-
cellular sites are accessible to the ligand. The overall binding 
curve would therefore reflect the existence of two types of GN 
binding sites: the already known G-protein and related sites 
and the extracellular sites that remain accessible in the vesicu-
lated preparation. 
Recent developments in the study of the spatial configura-
tion of the glutamate recognition site in the different iono-
tropic receptors (NMDA or non-NMDA) suggest the involve-
ment of three different regions in the transmitter/receptor 
interaction [19]. One of them includes the glycine-rich se-
quence (G)XGXXG known to be similar to the GN recogni-
tion site in the a subunit of G-proteins [10,20,21]. Occupation 
of this subsite by GNs would explain the displacement of 
glutamate and related agonists, as it has been finally demon-
strated by use of directed mutagenesis and specific antibodies 
[21]. 
If the GN receptor site is just part of the KA receptor (or, 
generally speaking, of the GLU receptor) the measured num-
bers (Bmax) of extracellular GN receptors (Fig. 3, Table 1) and 
of KA receptors (Fig. 1) should be reasonably similar. How-
ever, in our experiments with membranes, we observe a 1:4 
Table 2 
Purification of KA receptors from 10-day chick cerebellar membranes 
Purification step Binding of 40 nM Purification Recovery 
[3H]KA (pmol/mg) factor (%) 
Membranes 25 1 100 
Supernatant 50a 2 100 
DEAE-cellulose 160a 6 70 
ConA-agarose 230a 9 10 
ratio, favorable to the KA site (compare the KA 5 m a x in Fig. 
1 and the GppNHp i?max in vesicles, Table 1), whereas in the 
case of the purified receptor preparation the number of sites 
labeled by either ligand seems to be much the same (although 
binding assays with soluble receptor have a higher degree of 
inaccuracy). We cannot find an easy explanation for this dis-
crepancy since [3H]KA is displaced equally well by an excess 
of cold GppNHp in the membrane and the purified prepara-
tions. It may be conceived that the experimental conditions 
prevailing in binding experiments in the case of membranes 
would result in a limited accessibility of the GN to the mem-
brane site in the native conformation, thus discriminating 
against [3H] GppNHp binding at the relatively low ligand con-
centrations used in the saturation experiments (only a few 
pseudo-high affinity sites would be labeled: compare the K& 
of the membrane receptor in Table 1 and the estimated K& of 
the soluble receptor in Section 3.3), this effect being scarcely 
noticeable when a higher (0.4 mM) concentration of cold 
GppNHp is used in the KA displacement experiments. The 
lack of reciprocity in the displacement of KA by GNs in our 
membrane, and even in our partially purified preparations 
(only a partial displacement at the highest KA concentrations, 
although both KA and GLU have been reported to displace 
radioactive GTP in more purified receptor samples [14]) is 
equally puzzling. Perhaps, if the tertiary structure of the re-
ceptor, with the three-site interaction model mentioned above, 
is maintained under our experimental conditions - as would 
be expected to happen in the membrane, and perhaps (but less 
likely) in a partially purified receptor preparation - the lack of 
symmetry in the displacement could be explained if the KA 
and GN binding sites within the glycine-rich sequence do not 
totally coincide and provided that the very different size and 
shape of the two ligands leads to unidirectional steric hin-
drance at the level of one of the other two (preferentially) 
agonist recognizing sites. The above explanations may seem 
too labored but if we accept the alternative possibility that the 
GN receptor that we have characterized is not related to the 
KA receptor (also, in spite of the coincidence of the molecular 
mass, see Fig. 4), we would have to additionally explain our 
failure to detect and measure the binding of GppNHp truly 
responsible for the displacement of the excitatory agonist. 
Whatever the explanation, any sustained increase of the 
concentration of GNs in the vicinity of the KA receptor 
should effectively limit the access of the agonist, which brings 
us to the possible extracellular role of GNs in the CNS, if any. 
We lack precise data on the physiological presence of GMP or 
other guanine nucleotides in the extracellular space in the 
CNS and their hypothetical role as regulators of receptor 
activity. However, extracellularly acting guanine nucleotides 
(and nucleosides) have been, in the recent years, implicated 
in a number of trophic activities [22]. In any case, if they are 
at all present, or if they are at least released by cellular injury, 
Binding of 40 nM Displacement of 40 nM 
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in the same way as the amino acids themselves are released, 
they could help slow down the propagation of the excitotoxic 
wave to the neighboring cells [23]. Actually, we have recently 
shown that locally injected GMP can prevent quinolinic acid-
induced damage in the rat striatum [24]. Additionally, guanine 
nucleotides could serve as structural models to design a new 
type of glutamate antagonists potentially effective in the man-
agement of the excitotoxic component of CNS diseases. 
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